ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37,619,853 | -12.7% | 350,866 | -0.6% | 3.56% | -29.5% |
| Q4 2022 | $43,088,441 | -16.1% | 352,808 | -29.1% | 5.06% | -26.1% |
| Q3 2022 | $51,356,000 | +27.8% | 497,347 | +15.1% | 6.85% | -14.5% |
| Q2 2022 | $40,175,000 | +6.4% | 432,170 | +34.4% | 8.01% | -19.7% |
| Q1 2022 | $37,745,000 | +28.6% | 321,621 | +47.4% | 9.98% | +19.1% |
| Q4 2021 | $29,349,000 | – | 218,158 | – | 8.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |